Original Article
Pneumococcal Vaccination in Adults: What Can We Learn From Observational Studies That Evaluated PCV13 and PPV23 Effectiveness in the Same Population?
Eileen M. Dunnea,
, Catia Cillonizb,c, Claire von Mollendorfd,e, Joseph Lewnardf,g,h, Lindsay R. Granta, Mary P.E. Slacki, Luis Jodara, Christian Theilackera, Bradford D. Gessnera
Corresponding author
a Pfizer Vaccines, Collegeville, PA, USA
b Faculty of Health Sciences, Continental University, Huancayo, Peru
c Department of Pneumology, Hospital Clinic of Barcelona, Barcelona, Spain
d Infection and Immunity, Murdoch Children's Research Institute, Parkville, VIC, Australia
e Department of Paediatrics, The University of Melbourne, Parkville, VIC, Australia
f Division of Epidemiology, School of Public Health, University of California, Berkeley, CA, USA
g Division of Infectious Diseases & Vaccinology, School of Public Health, University of California, Berkeley, CA, USA
h Center for Computational Biology, College of Engineering, University of California, Berkeley, CA, USA
i School of Medicine & Dentistry, Griffith University, Gold Coast Campus, QLD, Australia
